Drug intelligence / Profile preview

Zuozhu Daxi

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine
Administration: Oral

Overview

Zuozhu Daxi (ZZDX) is a classic traditional Tibetan medicine developed by Xizang Ganlu Tibetan Medicine Co., Ltd. with a history of over 600 years. It is a complex oral pill formulation containing approximately 50 ingredients, including Calcite Lactis Praeparata, Herba Aconiti Tangutici, Croci Stigma, and notably, processed mercury and silver. The medicine is primarily used to treat a wide range of digestive system diseases, including chronic gastritis, gastric and duodenal ulcers, gastric cancer, and indigestion. Its therapeutic mechanism involves calming the liver, invigorating the stomach, and clearing heat. Research indicates it may also prevent Helicobacter pylori-induced gastric mucosal inflammation by inhibiting lipid metabolism.

Brand names: Zuozhu Daxi坐珠达西
Other names: ZZDXZuozhu-Daxi

Beyond the preview

Go deeper on Zuozhu Daxi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zuozhu Daxi.

Explore the full profile